Actelion To Appeal US Verdict In Asahi Kasei Licencing Dispute – NASDAQ
ZURICH -(Dow Jones)- Swiss biotech Actelion Ltd (ATLN.VX ... and the trial court's judgment are neither supported by the facts nor correct as a matter of law." Actelion said it "strongly believes there are significant grounds for a successful appeal."
Subscribe to LegalLaw247.Com Newsletter